Latest news
Damora Therapeutics, Inc. Common Stock (DMRA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeatMarketBeat · Wed, 05 Aug 2026 14:39:13 GMTDamora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 12:19:47 GMTDamora Begins Testing Antibody Designed for Monthly Doses - Stock TitanStock Titan · Wed, 05 Aug 2026 12:00:00 GMTDamora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila TimesThe Manila Times · Mon, 03 Aug 2026 20:10:08 GMT